Thesis Capital Announces 2026 EIR Cohort Fully Allocated; SIR Program Now Primary In-Residence Pathway

February 24, 2026 — Thesis Capital Partners today announced that its 2026 Entrepreneur-in-Residence (EIR) cohort is fully allocated, following strong interest from experienced operators seeking to acquire and scale lower middle market businesses in partnership with the firm.

The EIR pathway is designed for seasoned executives pursuing platform acquisitions generating $4+ million in EBITDA within the lower middle market. These transactions are typically structured with institutional capital and focused on building durable, scalable platforms positioned for long-term value creation through disciplined operations, strategic growth initiatives, and thoughtful capital allocation.

With the 2026 EIR cohort fully committed, Thesis will continue deploying capital alongside its current EIR partners while evaluating future cohort opportunities.

The firm's Searcher-in-Residence (SIR) program now represents the primary pathway for operators seeking to build in-residence with Thesis. The SIR program is designed for entrepreneurial leaders who want to identify, acquire, and operate a business with the full support of the Thesis platform — including deal sourcing, underwriting, capital access, and operational guidance.

SIR candidates typically target businesses with $1–$4 million in EBITDA and pursue a self-funded or lightly capitalized search structure, with Thesis providing a structured framework and institutional support throughout the process.

Operators interested in the SIR program are encouraged to reach out directly to explore fit and availability.